• info@steminsights.org

Triomics raises $15M Series A to automate cancer clinical trials matching

​[[{“value”:”

For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each year, only 3% to 5% of eligible patients enroll in investigations of new treatments. Triomics, a generative AI startup, claims it can significantly reduce the time it takes doctors to match […]

© 2024 TechCrunch. All rights reserved. For personal use only.

“}]]  

0

Leave a Reply

Your email address will not be published. Required fields are marked *

X